Open AccessCurrent issues around the pharmacotherapy of ADHD in children and adults
Author(s) -
Willemijn M. Meijer,
Adrianne Faber,
Els den Ban,
Hilde Tobi
Publication year - 2009
Publication title -
pharmacy world and science
Language(s) - English
Resource type - Journals
eISSN - 1573-739X
pISSN - 0928-1231
DOI - 10.1007/s11096-009-9302-3
Subject(s) - pharmacotherapy , atomoxetine , medicine , atomoxetine hydrochloride , psychiatry , methylphenidate , guideline , psychological intervention , psychosocial , attention deficit hyperactivity disorder , pathology
New drugs and new formulations enter the growing market for ADHD medication. The growing awareness of possible persistence of ADHD impairment beyond childhood and adolescence resulting in increased pharmacotherapy of ADHD in adults, is also a good reason for making an inventory of the what is generally known about pharmacotherapy in ADHD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom